Gunda Georg receives Carl Mannich medal

The Deutsche Pharmazeutische Gesellschaft (DPhG) has awarded our editorial advisory board member Prof. Dr. Gunda Georg the Carl Mannich medal 2023 for her outstanding achievements in the field of pharmaceutical sciences (Figure 1). Prof. Georg's scientific career began at the Philipps University of Marburg, where she studied pharmacy and obtained her doctorate in pharmaceutical chemistry under the supervision of Prof. Dr. Manfred Haake in 1980. After a postdoctoral fellowship at the University of Ottawa in Prof. Tony Durst's group and an appointment as Assistant Professor of Medicinal Chemistry at the University of Rhode Island, she joined the Department of Medicinal Chemistry at the University of Kansas in 1984, where she was named University Distinguished Professor in 1999. Since 2007, Prof. Dr. Georg continues to be Regents Professor at the Department of Medicinal Chemistry at the University of Minnesota and Director of the Institute for Therapeutics Discovery and Development as well as holder of the “Robert Vince Endowed Chair” and the “McKnight Presidential Chair in Medicinal Chemistry” with very great success until today. The results of her more than 40 years of research have been published in more than 250 original papers, two of them were recently published in our journal,[1, 2] and patents and have established her reputation as a world leader in medicinal chemistry. Particularly noteworthy is her work on the cancer therapeutics paclitaxel, the epothilones, and crypthophycins. She is coinventor of Lusedra®, which was marketed by Eisa Pharmaceuticals, and Minnelide®, an anticancer agent in Phase II clinical trials. Her current research areas include nonhormonal contraceptives for men[1] and women. She is co-inventor of YCT529, a selective retinoic acid receptor alpha antagonist that has been licensed by Your Choice Therapeutics and is scheduled for clinical trials in 2023. It will be the first nonhormonal male contraceptive to enter clinical trials. BBC Science Focus listed the discovery of YCT529 as #1 of the 19 most amazing science stories of 2022.[3] In her long research career, Prof. Dr. Georg has supervised and always supported more than 100 PhD students and postdocs with great commitment. In addition to the Carl Mannich medal of the German Pharmaceutical Society, she has received numerous other awards and prizes, of which only a few are mentioned here as representatives: In 2017, she was inducted into the Hall of Fame of the Division of Medicinal Chemistry of the American Chemical Society. In 2020, she became the first woman ever to receive the Alfred Burger Award in Medicinal Chemistry, one of the most prestigious awards in medicinal chemistry, for her outstanding achievements in the field. She was co-Editor-in-Chief of the Journal of Medicinal Chemistry from 2012 to 2020 and joined the Advisory Board of the Archiv der Pharmazie in 2021. We thank you very much for your continuous support of the Archiv and congratulate you, dear Gunda, very warmly on the award of the Carl Mannich medal. Wibke and Andreas

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.